Potocnik calls on industry to help identify market needs

European industrial leaders met members of the European Commission on 5 July to discuss the future of the European Technology Platform initiatives. Science and Research Commissioner Janez Potocnik outlined the value that the Commission places on these large-scale initiatives, but asked for leaders to search the road ahead and try to anticipate market needs.

Mr Potocnik addressed the Seminar of Industrial Leaders of European Technology Platforms and Associated Representatives of National Authorities in Brussels. He thanked the delegates for their input so far, especially in writing common visions and setting out Strategic Research Agendas.

He told the assembled delegates that the Technology Platform initiatives had strong support throughout the EU. "I can testify to a great level of commitment to European Technology Platforms right across the European institutions. This is not a surprise to me," he said. "Technology platforms are a competitive advantage for Europe in boosting our natural competitiveness," he said.

The Commissioner explained that he wanted to ensure that Technology Platforms contribute to 'lead market initiatives'. This initiative was first mooted at the Hampton Court summit in October 2005, which led to the expert group report on innovation, led by former Finnish Prime Minister Esko Aho. This report placed an emphasis on developing lead markets.

Technology Platforms were identified as key areas to maintain a competitive advantage for Europe, in "creating and exploiting innovation-friendly markets through the setting of research and innovation strategies at European level", he said.

Commissioner Potocnik identified four areas where Technology Platforms will help:

  • defining standards and high technical levels, as was done with the development of GSM;
  • public procurement to demand innovative products;
  • harmonised regulation to ensure a true single market;
  • intellectual property rights to ensure legal certainty.

"I call upon you, as companies, customers and regulators, to help us identify where the main obstacles and opportunities lie. In other words, you can help us anticipate future market needs and determine what needs to be done to realise these lead markets," he said.

The Commissioner stated that developing lead markets will help to increase the impact of the seventh Framework Programme (FP7), which will launch in early 2007. He also insisted on feedback. "Based on information we will receive from you - and from a wider consultation of stakeholders - the Commission services will identify some areas where we could take action and create conditions that promote technology-based innovation," or market opportunities which can be transformed into lead markets.

"With your guidance and support, Europe can achieve a world-leading position in driving markets for innovative goods and services and excellence in research in new technologies," he said.

For further information on Technology Platforms, please visit:
http://cordis.europa.eu/technology-platforms/home_en.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Accurately Classifies Pancreatic Cyst…

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance Imaging...